Stockscreener 앱 받기
3.52
11.04%
0.35
시간 외 거래:
3.59
0.07
+1.99%
전일 마감가:
$3.17
열려 있는:
$3.22
하루 거래량:
172.42K
Relative Volume:
0.97
시가총액:
$73.86M
수익:
-
순이익/손실:
$-94.11M
주가수익비율:
-0.5857
EPS:
-6.01
순현금흐름:
$-86.06M
1주 성능:
+14.29%
1개월 성능:
+39.68%
6개월 성능:
-20.00%
1년 성능:
-48.39%
1일 변동 폭
$3.18
$3.57
1주일 범위
$2.9297
$3.57
52주 변동 폭
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
명칭
Adverum Biotechnologies Inc
전화
(650) 649-1004
주소
100 CARDINAL WAY, REDWOOD CITY, CA
ADVM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
3.52 | 66.52M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-04-30 | 개시 | H.C. Wainwright | Buy |
| 2022-07-07 | 업그레이드 | Truist | Hold → Buy |
| 2021-07-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | 다운그레이드 | Truist | Buy → Hold |
| 2020-12-16 | 개시 | UBS | Neutral |
| 2020-11-12 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-05-05 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-03-16 | 개시 | SVB Leerink | Outperform |
| 2020-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-09-13 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-06-14 | 재개 | Raymond James | Mkt Perform |
| 2018-11-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | 다운그레이드 | SunTrust | Buy → Hold |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-08-30 | 개시 | SunTrust | Buy |
| 2018-02-15 | 재개 | Piper Jaffray | Overweight |
| 2017-10-12 | 개시 | Raymond James | Outperform |
모두보기
Adverum Biotechnologies Inc 주식(ADVM)의 최신 뉴스
Sentiment analysis tools applied to Adverum Biotechnologies Inc.Trade Analysis Summary & Scalable Portfolio Growth Ideas - Newser
How to use a screener to detect Adverum Biotechnologies Inc. breakouts2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
How does Adverum Biotechnologies Inc. compare to its peers2025 Macro Impact & Verified Trade Idea Suggestions - خودرو بانک
Adverum Biotechnologies’ Talent Acquisition and Equity Incentive Strategy: A Catalyst for Long-Term Value Creation - AInvest
Decoding Adverum Biotechnologies’ Talent Strategy: How Inducement Grants Under Nasdaq Rule 5635(c)(4) Signal Confidence in Long-Term Growth and Innovation in Ocular Gene Therapy - AInvest
Adverum Biotechnologies announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
16,860 Stock Options at $3.08: Adverum Biotechnologies Awards Inducement Grants to New Hires - Stock Titan
What’s the analyst consensus on Adverum Biotechnologies Inc.Product Launch & Verified Momentum Stock Watchlist - خودرو بانک
Is Adverum Biotechnologies Inc. exposed to political riskWall Street Watch & Technical Buy Zone Confirmations - خودرو بانک
Using Bollinger Bands to evaluate Adverum Biotechnologies Inc.Index Update & Risk Controlled Daily Trade Plans - Newser
Risk adjusted return profile for Adverum Biotechnologies Inc. analyzedWeekly Trading Summary & Community Verified Trade Signals - Newser
Real time breakdown of Adverum Biotechnologies Inc. stock performance2025 Momentum Check & High Win Rate Trade Alerts - Newser
What is the dividend yield of Adverum Biotechnologies Inc.Weekly Risk Summary & Free Fast Gain Swing Trade Alerts - خودرو بانک
Will Adverum Biotechnologies Inc. benefit from macro trendsMarket Rally & Long-Term Safe Investment Ideas - Newser
Will Adverum Biotechnologies Inc. rebound enough to break evenPortfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
Does Adverum Biotechnologies Inc. stock benefit from AI growth2025 Volume Leaders & Safe Entry Point Alerts - خودرو بانک
Will earnings trigger a reversal in Adverum Biotechnologies Inc.Weekly Stock Summary & High Accuracy Investment Entry Signals - Newser
Is Adverum Biotechnologies Inc. forming a bottoming base2025 Bull vs Bear & High Return Trade Opportunity Guides - Newser
What dividend growth rate does Adverum Biotechnologies Inc. offerJuly 2025 Gainers & Reliable Price Action Trade Plans - خودرو بانک
Trading Recap: Is Adverum Biotechnologies Inc. forming a breakout patternEarnings Growth Report & Weekly Breakout Opportunity Watchlist - خودرو بانک
Will Adverum Biotechnologies Inc. benefit from AI trendsPortfolio Gains Summary & Safe Swing Trade Setups - خودرو بانک
Applying Wyckoff theory to Adverum Biotechnologies Inc. stockWeekly Gains Summary & Weekly Watchlist for Consistent Profits - Newser
Key metrics from Adverum Biotechnologies Inc.’s quarterly dataJuly 2025 Summary & Real-Time Market Sentiment Reports - Newser
What is the long term forecast for Adverum Biotechnologies Inc. stockWeekly Trend Summary & Precise Swing Trade Alerts - khodrobank.com
Historical volatility pattern of Adverum Biotechnologies Inc. visualized2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Is a relief rally coming for Adverum Biotechnologies Inc. holdersJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - Newser
Is Adverum Biotechnologies Inc. likely to announce a buybackJuly 2025 Closing Moves & Weekly High Conviction Trade Ideas - خودرو بانک
Is Adverum Biotechnologies Inc. showing insider buyingMarket Sentiment Report & Precise Trade Entry Recommendations - خودرو بانک
Is Adverum Biotechnologies Inc. stock bottoming outEarnings Miss & Expert Verified Movement Alerts - Newser
Buybacks Report: Will Adverum Biotechnologies Inc. benefit from current market trendsJuly 2025 Selloffs & Daily Entry Point Trade Alerts - خودرو بانک
Detecting support and resistance levels for Adverum Biotechnologies Inc.Portfolio Risk Summary & Entry and Exit Point Strategies - Newser
How to interpret RSI for Adverum Biotechnologies Inc. stockForecast Cut & Precise Buy Zone Identification - Newser
Adverum Biotechnologies Inc. stock prediction for this week2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - Newser
Ranking Adverum Biotechnologies Inc. among high performing stocks via toolsEntry Point & Safe Entry Zone Tips - Newser
Heatmap analysis for Adverum Biotechnologies Inc. and competitorsWeekly Stock Report & Risk Controlled Swing Alerts - Newser
Adverum Biotechnologies Inc (ADVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adverum Biotechnologies Inc 주식 (ADVM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER |
May 15 '25 |
Sale |
2.00 |
924 |
1,848 |
13,768 |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR |
May 15 '25 |
Sale |
2.00 |
9,126 |
18,252 |
87,488 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 27 '25 |
Buy |
5.19 |
16,593 |
86,089 |
141,800 |
| Leonard Braden Michael | 10% Owner |
Apr 22 '25 |
Buy |
3.00 |
300,000 |
900,000 |
3,057,526 |
| Leonard Braden Michael | 10% Owner |
Apr 23 '25 |
Buy |
2.98 |
50,000 |
148,950 |
191,800 |
| Leonard Braden Michael | 10% Owner |
Mar 31 '25 |
Buy |
4.38 |
19,566 |
85,668 |
2,742,317 |
| Leonard Braden Michael | 10% Owner |
Apr 02 '25 |
Buy |
4.04 |
15,209 |
61,408 |
2,757,526 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 18 '25 |
Buy |
4.69 |
62,341 |
292,418 |
2,667,161 |
1.40%
자본화:
|
볼륨(24시간):